Potential Efficacy of Midazolam as Second-Line Treatment for Terminal Dyspnea in Patients with Cancer: Secondary Analysis of a Multicenter Prospective Cohort Study

Author:

Miwa Satoru1,Mori Masanori2,Yamaguchi Takashi3ORCID,Suzuki Kozue4,Matsuda Yoshinobu5ORCID,Matsunuma Ryo6,Watanabe Hiroaki7,Ikari Tomoo8,Matsumoto Yoshihisa9,Imai Kengo1,Yokomichi Naosuke2ORCID,Yamauchi Toshihiro1,Okamoto Soichiro10,Inoue Satoshi1,Inoue Akira8,Morita Tatsuya2,Satomi Eriko11,

Affiliation:

1. Seirei Hospice, Seirei Mikatahara General Hospital, Hamamatsu, Japan.

2. Palliative and Supportive Care Division, Seirei Mikatahara General Hospital, Hamamatsu, Japan.

3. Department of Palliative Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.

4. Department of Palliative Care, Tokyo Metropolitan Cancer and Infectious Disease Center Komagome Hospital, Tokyo, Japan.

5. Department of Psychosomatic Internal Medicine, National Hospital Organization Kinki-Chuo Chest Medical Center, Sakai, Japan.

6. Division of Palliative Care, Department of Medicine, Konan Medical Center, Kobe, Japan.

7. Home Palliative Care Asunaro Clinic, Komaki, Japan.

8. Department of Palliative Medicine, Tohoku University School of Medicine, Sendai, Japan.

9. Department of Palliative Therapy, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.

10. Uguisu Home Care Clinic, Hamamatsu, Japan.

11. Department of Palliative Medicine, National Cancer Center Hospital, Tokyo, Japan.

Publisher

Mary Ann Liebert Inc

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3